What Happened?
, -based Be Biopharma Appointed Angus Smith as Chief Financial Officer
Date of management change: January 12, 2024
, -based Be Biopharma Appointed Angus Smith as Chief Financial Officer
Be Biopharma is a leader in developing B cells as medicines, treating disease with the human body`s native protein factories. We precisely engineer B cells to harness their intrinsic drug-like properties – remarkable protein production, selective tissue targeting, and fine control of their cellular environment – to forge a new category of cell therapy. These medicines are designed to be durable, allogeneic, re-dosable, and administered without toxic conditioning, creating new avenues to halt or reverse severe diseases like cancer, autoimmune conditions, and enzyme deficiency. Founded by Longwood Fund and B cell engineering pioneers David Rawlings, M.D., and Richard James, Ph.D., Be Biopharma is re-imagining medicine based on the power of B cell therapy. Be Bio was founded in October 2020 by Longwood Fund with a $52 million Series A investment led by Atlas Ventures and RA Capital, joined by Alta Partners and Takeda Ventures.
Angus Smith is Chief Financial Officer at Be Biopharma. Previously, Angus held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Hintze Jim, Washington Delinda, Coplen Erica, Crawford Taylor, Bhaskaran Pradeep, Smith Gordon, Lamb Jeff, Tournadre Frederic, Honz Patrice, Matsui Matt, Rabinovich Adelina
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.